3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
8
Colonic Neoplasms
5
Motor Activity
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Weight Loss
1
Urologic Neoplasms
1
Smoking Cessation
1
Sarcopenia
1
Recurrence
1
Rectal Neoplasms
1
Polyps
1
Patient Compliance
1
Pancreatitis, Chronic
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Diabetes Mellitus, Type 2
1
Colorectal Cancer Prevention
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Anastomotic Leak
1
Interventions
Oxaliplatin
10
Gemcitabine
8
Cisplatin
7
Hepatectomy
6
Fluorouracil
6
Radiofrequency Ablation
5
Liver Transplantation
5
Irinotecan
5
Capecitabine
5
lenvatinib
4
Paclitaxel
4
Neoadjuvant Therapy
4
Folfox protocol
4
Cetuximab
4
Aspirin
4
tislelizumab
3
Surgical Procedures, Operative
3
Nivolumab
3
Carboplatin
3
titanium silicide
2
durvalumab
2
apatinib
2
Trastuzumab
2
S 1 (combination)
2
Leucovorin
2
Lamivudine
2
Introns
2
Ethiodized Oil
2
Drug Therapy
2
DNA, Mitochondrial
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Diet
×
Gastrointestinal
×
Clear all
NCT07494201
2026-03-27
MIMICC
Fondazione del Piemonte per l'Oncologia
Phase NA
Recruiting
2,500 enrolled